Recorded
Jun
,
2025
Virtual event on-demand
Virtual event
Recorded
Virtual event
Join the PharmaVoice and BioPharma Dive editorial teams for an exclusive event where our journalists will speak with top executives and experts to discuss the state of cancer drug research, its evolution and development.
This event will provide expert perspectives on the trends shaping oncology. Attendees will gain firsthand insights into the industry’s pipeline strategies, key takeaways from the American Society of Clinical Oncology’s annual meeting and the growing role of China-based drug developers.
What to expect:
- One-on-one discussions with industry leaders spotlighting pipeline strategies for antibody-drug conjugates and immunotherapies
- Expert panel discussions on the most consequential ASCO data and how it may shift cancer research and treatment
- A global perspective on the role of China-based drug companies and their influence on the field
Who should attend?
- Executives and employees at oncology-focused companies
- Cancer researchers and physicians, especially those following the 2025 ASCO meeting
- Partners and associates at venture capital firms
- Other professionals in the biopharma and healthcare space
Reserve Your Spot Today!
Event powered by
No items found.
Speakers
About our newsroom
Interested in sponsoring an event like this?
Our best-in-class editorial virtual events provide lead generation with lead guarantees, brand visibility through promotion alongside our publications, and thought leadership opportunities to speak directly to our engaged audience on topics that matter most to them.
